Skip to main content
Equibles
CBIO $17.75 -0.06%
CBIO logo
CBIO · Crescent Biopharma, Inc.
Track CBIO — free

Use CBIO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CBIO

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$17.75 -0.01 (-0.06%) At close · Aug 28
Russell 2000 member Rebalance outlook locked
Market Cap
$657.08M
Shares
37.14M
All earnings calls

Earnings call · FY2022 Q2

Crescent Biopharma, Inc. (CBIO) Q2 2022 Earnings Call

Concluded Aug 3, 2022
Aug 3, 2022 0 turns
Period
FY2022 Q2
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $75,000 +52716.9% YoY
Diluted EPS -$25.00
Net income -$13.27M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 3, 2022 10-Q report Filed Aug 3, 2022

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Dividend / share
$143.00
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)